Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D005343:Fibrinolytic Agents; D006098:Granulocytes / Q000187:drug effects; D010276:Parasympatholytics; D010919:Placebos; D010974:Platelet Aggregation / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D011817:Rabbits; D012772:Shock, Septic / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy
D005343:Fibrinolytic Agents; D010276:Parasympatholytics; D010919:Placebos; D011412:Propanolamines; D004176:Dipyridamole; D001241:Aspirin